Table 1 Clinical summary of patients from this study
Summary | Non-hospitalized | Hospitalized | ICU |
|---|---|---|---|
Samples, no (%) | 24 (63) | 14 (37) | 4 (10.5) |
Age, median (IQR) | 56 (34.3–63.0) | 66.5 (56.5–85.3) | 60 (55.5–64.5) |
Sex, female/male | 14/10 | 4/10 | 0/4 |
Days to sampling from first COVID-19 positive test, median (IQR) | 37 (24.0–48.5) | 82 (38.5–93.8) | 62.5 (15.3–91.8) |
Days to admission from onset of symptoms, median no (IQR) | N/A | 6 (2–9.8) | 2.5 (0.5–5.3) |
Symptom, no (%) | |||
Asymptomatic | 1 (4.2) | 0 (0) | 0 (0) |
Fever | 9 (37.5) | 7 (50) | 3 (75) |
Cough | 10 (41.7) | 9 (64.3) | 2 (50) |
Shortness of breath | 1 (4.2) | 7 (50) | 2 (50) |
Co-morbidities, no (%) | |||
Diabetes | 3 (12.5) | 0 (0) | 0 (0) |
Cardiac illnesses | 2 (8.3) | 2 (14.3) | 0 (0) |
Vascular illnesses | 3 (12.5) | 10 (71.4) | 3 (75) |
Pulmonary illnesses | 1 (4.2) | 2 (14.3) | 0 (0) |
Renal illnesses | 0 (0) | 2 (14.3) | 1 (25) |
Neuro-muscular illnesses | 0 (0) | 0 (0) | 0 (0) |
Liver illnesses | 0 (0) | 0 (0) | 0 (0) |
Gastro-intestinal illnesses | 0 (0) | 0 (0) | 0 (0) |
Cancer conditions | 1 (4.2) | 2 (14.3) | 0 (0) |
Rheumatologic illnesses | 1 (4.2) | 0 (0) | 0 (0) |
Mental health diagnosis | 0 (0) | 3 (21.4) | 0 (0) |
Immuno-compromising condition | 0 (0) | 0 (0) | 0 (0) |
Intubation | N/A | 2 (14.3) | 2 (50) |
